期刊文献+

非小细胞肺癌脑转移瘤的放疗疗效评价及预后分析 被引量:6

Evalauation effects of radiotherphy for brain metastases of non-small-cell lung carcinoma and muti-factor analysis of the prognosis
下载PDF
导出
摘要 目的:评价非小细胞肺癌脑转移瘤患者接受两种不同放疗的疗效和生存预后因素。方法:对54例非小细胞肺癌脑转移患者进行放疗,其中行全脑+三维适形放疗37例,单纯三维适形放疗17例,用Kaplan-meier法统计生存率,以Cox比例风险模型分析影响患者生存的预后因素。结果:全脑+三维适形放疗中位生存期9个月,单纯三维适形放疗中位生存期7个月,两组差异无统计学意义(P>0.05)。结论:非小细胞肺癌脑转移三维适形放疗联合全脑照射无生存得益,多因素分析提示分级和脑转移肿瘤个数是影响预后的关键性因素。 Objective:To evaluate the therapeutic effects and factors affecting the patients′ survival of two different radiotherapies in the treatment of brain metastases of non-small-cell lung carcinoma(NSCLC).Methods:In the fifty-four cases of brain metastases of NSCLC receiving radiotherapy,37 cases were treated with three-dimensional conformal radiotherapy(3D-CRT) and whde brain radiotherapy(WBR),while the other 17 underwent 3D-CRT alone.Kaplan-Meier method was used to analyze the survival rate and local control rate,and Cox proportional hazards model was applied for determining the prognostic factors influencing the patients′ survival.Results:The median survival was 9 months for the patients who received 3D-CRT and WBR,The median survival was 7 monthes for the patients who simply received 3D-CRT.Statistics detected no significant difference between the two groups(P0.05).Multivariate analysis showed that the recursive portioning analysis(RPA) and metastasis numbers were the independent prognostic factors for the patients′survival.Conclusions:WBR combined with 3D-CRT did not benefit the patients with brain metastases of NSCLC for their survival.RPA and metastasis numbers were the independent prognostic factors for the patients′survival.
出处 《蚌埠医学院学报》 CAS 2010年第7期668-671,共4页 Journal of Bengbu Medical College
关键词 非小细胞肺 脑转移瘤 三维适形放疗 预后 non-small-cell lung carcinoma brain metastasis three-dimensional conformal radiotherapy prognosis
  • 相关文献

参考文献11

  • 1赵森.转移性恶性肿瘤的治疗[M]//汤钊猷.现代肿瘤学.上海:上海医科大学出版社,2000:531-553.
  • 2Gaspar L,Scott C,Rotman M,et al.Recursive partitioning analysis(RPA) of prognostic factors in three Radiation Therapy Oncology Group(RTOG) brain metastases trials[J].Int J Radiat Oncol Biol Phys,1997,37(4):745-751.
  • 3Ranjan T,Abrey LE.Current management of metastatic brain disease[J].Neurotherapeutics,2009,6(3):598-603.
  • 4Zabel A,Debus J.Treatment of brain metastases from non-small-cell lung cancer(NSCLC):radiotherapy[J].Lung Cancer,2004,45(Suppl 2):247-252.
  • 5Zabel A,Milker-Zabel S,Thilmann C,et al.Treatment of brain metastases in patients with non-small cell lung cancer(NSCLC) by stereotactic linac-based radiosurgery:prognostic factors[J].Lung Cancer,2002,37(1):87-94.
  • 6Noel G,Medioni J,Valery CA,et al.Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer[J].Lung Cancer,2003,41(3):333-343.
  • 7Sneed PK,Suh JH,Goetsch SJ,et al.A multi-institutional review of radiosurgery alone vs.radiosurgery with whole brain radiotherapy as the initial management of brain metastases[J].Int J Radiat Oncol Biol Phys,2002,53(3):519-526.
  • 8Karlovits BJ,Quigley MR,Karlovits SM,et al.Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease:challenging the tradition of adjuvant whole-brain radiotherapy[J].Neurosurg Focus,2009,27(6):E7.
  • 9Patil CG,Pricola K,Garg SK,et al.Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases[J].Cochrane Database Syst Rev,2010,16(6):CD006121.
  • 10Narita Y,Shibui S.Strategy of surgery and radiation therapy for brain metastases[J].Int J Clin Oncol,2009,14(4):275-280.

共引文献3

同被引文献26

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部